Cited by 172

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation

van Horssen, Jack, Singh, Shailender, van der Pol, Susanne, Kipp, Markus, Lim, Jamie L, Peferoen, Laura, Gerritsen, Wouter, Kooi, Evert-Jan, Witte, Maarten E, Geurts, Jeroen JG, de Vries, Helga E, Peferoen-Baert, Regina, van den Elsen, Peter J, van der Valk, Paul, Amor, Sandra·2012·Journal of Neuroinflammation

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-9-156

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In preactive lesions, microglia produce NADPH oxidase and increase harmful oxidative stress that may contribute to neuronal injury.

    “In the “preactive” lesions, microglia produce NADPH oxidase and increase harmful oxidative stress that may contribute to neuronal injury (Horssen et al. 2012).”
  • Microglial activation occurs as an initial pathological process in the early stages of inflammation and demyelination, even before T-cell infiltration in RRMS, PPMS, and SPMS.

    “Microglial activation occurs as an initial pathological process in the early stages of inflammation and demyelination, even before T-cell infiltration in RRMS, PPMS, and SPMS, because microglial nodules have been detected in normal-appearing white matter in the early stages (Horssen et al. 2012).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ: Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003, 62:723–732. · DOI · Paper page
  2. Barnett MH, Prineas JW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004, 5:458–468. · DOI
  3. Amor S, Puentes F, Baker D, van der Valk P: Inflammation in neurodegenerative diseases. Immunology 2010, 129:154–169. · DOI · Paper page
  4. Lassmann H, Suchanek G, Ozawa K: Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994, 36:S42-S46. · DOI
  5. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD: Macrophages and neurodegeneration. Brain Res Brain Res Rev 2005, 48:185–195. · DOI
  6. Nataf S: Neuroinflammation responses and neurodegeneration in multiple sclerosis. Rev Neurol (Paris) 2009, 165:1023–1028. · DOI
  7. Van Horssen J, Witte ME, Schreibelt G, de Vries HE: Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta 2011, 1812:141–150. · DOI
  8. Lassmann H, van Horssen J: The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011, 23:3715–3723. · DOI
  9. der Valk V, De Groot CJ: Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000, 1:2–10. · DOI
  10. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165–3172. · DOI · Paper page
  11. De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P: Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001, 124:1635–1645. · DOI
  12. Linker R, Gold R, Luhder F: Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol 2009, 29:43–68. · DOI
  13. Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ: Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 1997, 130:2800–2815. · DOI · Paper page
  14. van Noort JM, van den Elsen PJ, van Horssen J, Geurts JJ, van der Valk P, Amor S: Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets 2011, 10:68–81. · DOI
  15. Van Horssen J, Schreibelt G, Bo L, Montagne L, Drukarch B, van Muiswinkel F, de Vries HE: NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic Biol Med 2006, 41:311–317. · DOI
  16. Verhoeven AJ, Bolscher BG, Meerhof LJ, van Zwieten R, Keijer J, Weening RS, Roos D: Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood 1989, 6:1686–1694. · DOI
  17. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Mahad D, Bradl M, van Horssen J, Lassmann H: NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 2012, 135:886–899. · DOI · Paper page
  18. Trapp BD, Nave KA: Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008, 31:247–269. · DOI · Paper page
  19. Aboul-Enein F, Krssak M, Hoftberger R, Prayer D, Kristoferitsch W: Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. PLoS One 2010, 5:e11625. · DOI
  20. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD: Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001, 57:1248–1252. · DOI
  21. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N: Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 2003, 13:554–73. · DOI
  22. Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ: A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 2008, 131:3092–3102. · DOI · Paper page
  23. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N: Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008, 131:288–303. · DOI
  24. Allen IV, McQuaid S, Mirakhur M, Nevin G: Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 2001, 22:141–144. · DOI
  25. Caminero A, Comabella M, Montalban X: Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story. J Neuroimmunol 2011, 234:1–6. · DOI
  26. Zeis T, Probst A, Steck AJ, Stadelmann C, Bruck W, Schaeren-Wiemers N: Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 2009, 19:459–466. · DOI · Paper page
  27. Van Noort JM, Bsibsi M, Gerritsen WH, van der Valk P, Bajramovic JJ, Steinman L, Amor S: Alpha b-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol 2010, 7:694–703. · DOI
  28. Witte ME, Bo L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J: Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 2009, 2:193–204. · DOI
  29. Mahad D, Ziabreva I, Lassmann H, Turnbull D: Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008, 131:1722–1735. · DOI · Paper page
  30. Stirling DP, Stys PK: Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med 2010, 16:160–170. · DOI
  31. Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J: Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 2010, 5:411–418. · DOI

Cited by

Sorted by citations

Metadata

Authors
van Horssen, J., Singh, S., van der Pol, S., Kipp, M., Lim, J. L., Peferoen, L., Gerritsen, W., Kooi, E.-J., Witte, M. E., Geurts, J. J., de Vries, H. E., Peferoen-Baert, R., van den Elsen, P. J., van der Valk, P., & Amor, S.
Venue
Journal of Neuroinflammation
Published
2012-07-02
Volume
9
Issue
1
ISSN
1742-2094
Cited by
172
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review